Correction to: miR-330-5p targets SPRY2 to promote hepatocellular carcinoma progression via MAPK/ERK signaling

Detalles Bibliográficos
Autores principales: Xiao, Shuai, Yang, Mengyuan, Yang, Hao, Chang, Ruimin, Fang, Feng, Yang, Lianyue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277786/
https://www.ncbi.nlm.nih.gov/pubmed/34257271
http://dx.doi.org/10.1038/s41389-021-00340-z
_version_ 1783722127100215296
author Xiao, Shuai
Yang, Mengyuan
Yang, Hao
Chang, Ruimin
Fang, Feng
Yang, Lianyue
author_facet Xiao, Shuai
Yang, Mengyuan
Yang, Hao
Chang, Ruimin
Fang, Feng
Yang, Lianyue
author_sort Xiao, Shuai
collection PubMed
description
format Online
Article
Text
id pubmed-8277786
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-82777862021-07-20 Correction to: miR-330-5p targets SPRY2 to promote hepatocellular carcinoma progression via MAPK/ERK signaling Xiao, Shuai Yang, Mengyuan Yang, Hao Chang, Ruimin Fang, Feng Yang, Lianyue Oncogenesis Correction Nature Publishing Group UK 2021-07-13 /pmc/articles/PMC8277786/ /pubmed/34257271 http://dx.doi.org/10.1038/s41389-021-00340-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correction
Xiao, Shuai
Yang, Mengyuan
Yang, Hao
Chang, Ruimin
Fang, Feng
Yang, Lianyue
Correction to: miR-330-5p targets SPRY2 to promote hepatocellular carcinoma progression via MAPK/ERK signaling
title Correction to: miR-330-5p targets SPRY2 to promote hepatocellular carcinoma progression via MAPK/ERK signaling
title_full Correction to: miR-330-5p targets SPRY2 to promote hepatocellular carcinoma progression via MAPK/ERK signaling
title_fullStr Correction to: miR-330-5p targets SPRY2 to promote hepatocellular carcinoma progression via MAPK/ERK signaling
title_full_unstemmed Correction to: miR-330-5p targets SPRY2 to promote hepatocellular carcinoma progression via MAPK/ERK signaling
title_short Correction to: miR-330-5p targets SPRY2 to promote hepatocellular carcinoma progression via MAPK/ERK signaling
title_sort correction to: mir-330-5p targets spry2 to promote hepatocellular carcinoma progression via mapk/erk signaling
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277786/
https://www.ncbi.nlm.nih.gov/pubmed/34257271
http://dx.doi.org/10.1038/s41389-021-00340-z
work_keys_str_mv AT xiaoshuai correctiontomir3305ptargetsspry2topromotehepatocellularcarcinomaprogressionviamapkerksignaling
AT yangmengyuan correctiontomir3305ptargetsspry2topromotehepatocellularcarcinomaprogressionviamapkerksignaling
AT yanghao correctiontomir3305ptargetsspry2topromotehepatocellularcarcinomaprogressionviamapkerksignaling
AT changruimin correctiontomir3305ptargetsspry2topromotehepatocellularcarcinomaprogressionviamapkerksignaling
AT fangfeng correctiontomir3305ptargetsspry2topromotehepatocellularcarcinomaprogressionviamapkerksignaling
AT yanglianyue correctiontomir3305ptargetsspry2topromotehepatocellularcarcinomaprogressionviamapkerksignaling

Ejemplares similares